New insights into diffuse large B-cell lymphoma pathobiology
AG Solimando, T Annese, R Tamma, G Ingravallo… - Cancers, 2020 - mdpi.com
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL),
accounting for about 40% of all cases of NHL. Analysis of the tumor microenvironment is an …
accounting for about 40% of all cases of NHL. Analysis of the tumor microenvironment is an …
[HTML][HTML] Diffuse large B-cell lymphoma's new genomics: the bridge and the chasm
JL Crombie, P Armand - Journal of Clinical Oncology, 2020 - ncbi.nlm.nih.gov
The clinical and molecular heterogeneity of diffuse large B-cell lymphoma (DLBCL), even
beyond the recent WHO reclassification, 1 is well recognized.(For simplicity, this review will …
beyond the recent WHO reclassification, 1 is well recognized.(For simplicity, this review will …
SOHO state of the art updates and next questions: prophylaxis and management of secondary CNS lymphoma
J Simard, M Roschewski - Clinical Lymphoma Myeloma and Leukemia, 2022 - Elsevier
Secondary CNS lymphoma (SCNSL) is a rare but frequently fatal complication of systemic
lymphoma. There is no standard treatment for SCNSL, and patients who develop SCNSL at …
lymphoma. There is no standard treatment for SCNSL, and patients who develop SCNSL at …
Új molekuláris klasszifikációs rendszerek diffúz nagy B-sejtes limfómában
Összefoglaló. A diffúz nagy B-sejtes limfóma (DLBCL) a leggyakoribb non-Hodgkin-limfóma
(NHL), az összes NHL-es eset mintegy 40%-a tartozik ide. A betegek kétharmada az első …
(NHL), az összes NHL-es eset mintegy 40%-a tartozik ide. A betegek kétharmada az első …